Skip to main content
Premium Trial:

Request an Annual Quote

Indivumed nRavel

Individumed has introduced nRavel, an artificial intelligence-based multiomic informatics platform for precision oncology drug discovery. The new product adds a suite of analytics and machine learning tools to the company's multiomic cancer database, IndivuType, to assist target discovery and drug development for its pharmaceutical customers. The first release of nRavel features "toolboxes" for immuno-oncology, pathways and signaling, biomarkers, genomics, signatures, and clinical analytics. The Hamburg, Germany-based company said that it anticipates more applications in the future.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.